BCM
PFE icon

BlueCrest Capital Management’s Pfizer PFE Stock Holding History

BlueCrest Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-122,200
Closed -$3.39M – 202
2024
Q1 		$3.39M Sell
122,200
-120,000
-50% -$3.33M 0.17% 88
2023
Q4 		$6.97M Buy
242,200
+109,800
+83% +$3.32M 0.27% 75
2023
Q3 		$4.39M Sell
132,400
-58,700
-31% -$2.08M 0.19% 81
2023
Q2 		$7.01M Buy
+191,100
New +$7.44M 0.23% 56

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BlueCrest Capital Management's PFE Position: Q2 2024 in Review

BlueCrest Capital Management sold out of Pfizer (PFE) in Q2 2024, closing a stake of 87,036 shares — an estimated $2.42M sold.

BlueCrest Capital Management first reported a position in PFE in Q3 2016 and held it in 14 quarters. The position peaked at $15.8M in Q2 2018. 2,873 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

  • BlueCrest Capital Management reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
  • BlueCrest Capital Management sold 87,036 Pfizer shares in Q2 2024, an estimated $2.42M.
  • BlueCrest Capital Management first reported a position in Pfizer in Q3 2016 and held it in 14 quarters.
  • BlueCrest Capital Management's Pfizer position peaked at $15.8M in Q2 2018.
  • 2,873 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on BlueCrest Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.